Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University of Leeds, Leeds LS2 9JT, UK.
Leeds Institute for Data Analytics and Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
Europace. 2022 Jan 4;24(1):165-172. doi: 10.1093/europace/euab193.
To develop a suite of quality indicators (QIs) for the evaluation of the care and outcomes for adults undergoing cardiac pacing.
Under the auspice of the Clinical Practice Guideline Quality Indicator Committee of the European Society of Cardiology (ESC), the Working Group for cardiac pacing QIs was formed. The Group comprised Task Force members of the 2021 ESC Clinical Practice Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy, members of the European Heart Rhythm Association, international cardiac device experts, and patient representatives. We followed the ESC methodology for QI development, which involved (i) the identification of the key domains of care by constructing a conceptual framework of the management of patients receiving cardiac pacing, (ii) the development of candidate QIs by conducting a systematic review of the literature, (iii) the selection of the final set of QIs using a modified-Delphi method, and (iv) the evaluation of the feasibility of the developed QIs. Four domains of care were identified: (i) structural framework, (ii) patient assessment, (iii) pacing strategy, and (iv) clinical outcomes. In total, seven main and four secondary QIs were selected across these domains and were embedded within the 2021 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization therapy.
By way of a standardized process, 11 QIs for cardiac pacing were developed. These indicators may be used to quantify adherence to guideline-recommended clinical practice and have the potential to improve the care and outcomes of patients receiving cardiac pacemakers.
开发一套用于评估成人心脏起搏治疗的护理和结局的质量指标(QIs)。
在欧洲心脏病学会(ESC)临床实践指南质量指标委员会的支持下,成立了心脏起搏 QIs 工作组。该工作组由 2021 年 ESC 心脏起搏和心脏再同步治疗临床实践指南的工作组成员、欧洲心律协会成员、国际心脏器械专家和患者代表组成。我们遵循 ESC 的 QI 开发方法,该方法包括:(i)通过构建接受心脏起搏治疗的患者管理概念框架来确定护理的关键领域;(ii)通过系统评价文献来开发候选 QIs;(iii)使用改良 Delphi 法选择最终的 QIs 集;(iv)评估开发的 QIs 的可行性。确定了四个护理领域:(i)结构框架,(ii)患者评估,(iii)起搏策略,和(iv)临床结局。在这些领域中总共选择了七个主要和四个次要 QIs,并将其嵌入 2021 年 ESC 心脏起搏和心脏再同步治疗指南中。
通过标准化的流程,开发了 11 项心脏起搏 QIs。这些指标可用于量化对指南推荐的临床实践的依从性,并有可能改善接受心脏起搏器的患者的护理和结局。